GR1002143B - New oligodeoxyribonucleotides having anti-ischemic activity and methods of preparation thereof. - Google Patents

New oligodeoxyribonucleotides having anti-ischemic activity and methods of preparation thereof.

Info

Publication number
GR1002143B
GR1002143B GR920100527A GR920100527A GR1002143B GR 1002143 B GR1002143 B GR 1002143B GR 920100527 A GR920100527 A GR 920100527A GR 920100527 A GR920100527 A GR 920100527A GR 1002143 B GR1002143 B GR 1002143B
Authority
GR
Greece
Prior art keywords
preparation
methods
ischemic activity
oligodeoxyribonucleotides
new
Prior art date
Application number
GR920100527A
Other languages
Greek (el)
English (en)
Other versions
GR920100527A (el
Inventor
Marisa Mantovani
Danilo Moltrasio
Ennio Lanzarotti
Giuseppe Prino
Roberto Porta
Armando Cedro
Original Assignee
Crinos Industria Farmaco
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Crinos Industria Farmaco filed Critical Crinos Industria Farmaco
Publication of GR920100527A publication Critical patent/GR920100527A/el
Publication of GR1002143B publication Critical patent/GR1002143B/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
GR920100527A 1991-12-09 1992-11-26 New oligodeoxyribonucleotides having anti-ischemic activity and methods of preparation thereof. GR1002143B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI913294A IT1252174B (it) 1991-12-09 1991-12-09 Oligodesossimibonucleotidi ad attivita' antiischemica e procedimenti per il loro ottenimento

Publications (2)

Publication Number Publication Date
GR920100527A GR920100527A (el) 1994-03-31
GR1002143B true GR1002143B (en) 1996-02-16

Family

ID=11361289

Family Applications (1)

Application Number Title Priority Date Filing Date
GR920100527A GR1002143B (en) 1991-12-09 1992-11-26 New oligodeoxyribonucleotides having anti-ischemic activity and methods of preparation thereof.

Country Status (17)

Country Link
US (3) US6046172A (fr)
EP (1) EP0558833A3 (fr)
JP (1) JPH05247083A (fr)
CN (1) CN1073448A (fr)
AU (1) AU655087B2 (fr)
BE (1) BE1008163A5 (fr)
BR (1) BR9204931A (fr)
CA (1) CA2083416A1 (fr)
CH (1) CH685298A5 (fr)
FR (1) FR2684675B1 (fr)
GR (1) GR1002143B (fr)
IL (1) IL103757A (fr)
IT (1) IT1252174B (fr)
LU (1) LU88197A1 (fr)
MX (1) MX9207137A (fr)
PT (1) PT101113A (fr)
ZA (1) ZA928878B (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1271685B (it) * 1994-08-03 1997-06-04 Crinos Industria Farmaco Impiego dei polidesossiribonucleotidi nelle neuropati diabetiche
AU754242B2 (en) * 1997-04-28 2002-11-07 Arsinur Burcoglu Method of treating HIV infection and related secondary infections thereof
ES2251134T3 (es) * 1999-06-08 2006-04-16 Gentium S.P.A. Uso de complejos entre liposomas cationicos y polidesoxirribonucleotidos como medicamentos.
EP1325962A1 (fr) * 2001-12-17 2003-07-09 Gentium S.p.A. Procédé pour la détermination de l'activité biologique de la defibrotide
BR0315005B1 (pt) * 2002-10-01 2017-11-14 Truck Lite Co "led headlight"
US7270723B2 (en) * 2003-11-07 2007-09-18 Kimberly-Clark Worldwide, Inc. Microporous breathable elastic film laminates, methods of making same, and limited use or disposable product applications
ITMI20031714A1 (it) * 2003-09-05 2005-03-06 Gentium Spa Formazioni ad azione antitumorale.
ITMI20050336A1 (it) * 2005-03-03 2006-09-04 Gentium Spa Formulazione ad attivita' anti-tumorale
AU2006222045B2 (en) * 2005-03-03 2011-10-20 Gentium Spa Oligodeoxyribonucleotides of 4000-10000 Dalton for treating tumors
EP1872787A1 (fr) * 2006-06-27 2008-01-02 Gentium S.p.A. Utilisation de defibrotide pour l'inhibition de l'heparanase
EP1982722A1 (fr) * 2007-04-16 2008-10-22 Gentium S.p.A. Utilisation de oligotide pour le traitement de maladies rénales
EP2103689A1 (fr) 2008-03-19 2009-09-23 Gentium S.p.A. Oligonucléotides phosphodiesters synthétiques et leurs utilisations thérapeutiques
EP2637672B1 (fr) 2010-11-12 2018-08-22 Gentium S.r.l. Défibrotide pour une utilisation dans la prophylaxie et/ou le traitement de la maladie du greffon contre l'hôte (mgch)
ES2660969T5 (es) 2012-06-22 2021-09-03 Gentium S R L Método basado en euglobulina para determinar la actividad biológica de defibrotida
EP3026122A1 (fr) 2014-11-27 2016-06-01 Gentium S.p.A. Procédé à base cellulaire pour déterminer la puissance de défibrotide
TW201909904A (zh) 2017-08-03 2019-03-16 愛爾蘭商爵士製藥愛爾蘭有限責任公司 高濃度調配物
CN112236149A (zh) 2018-04-12 2021-01-15 贾兹制药公司 用于预防和治疗细胞因子释放综合征和与免疫耗竭相关的神经毒性的去纤苷
US20220023533A1 (en) 2018-12-07 2022-01-27 Jazz Phrmaceticals Ireland Limited Subcutaneous delivery of high concentration formulations
EP4110287A1 (fr) 2020-02-28 2023-01-04 Jazz Pharmaceuticals Ireland Limited Administration de formulations de faible viscosité
WO2021212055A1 (fr) 2020-04-17 2021-10-21 Jazz Pharmaceuticals Ireland Limited Traitement de défibrotide pour la prévention d'un rejet et d'une lésion d'organe
TW202308659A (zh) 2021-05-06 2023-03-01 愛爾蘭商爵士製藥愛爾蘭有限責任公司 用於急性呼吸窘迫症候群之治療及預防的去纖維蛋白多核苷酸

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1142365B (de) * 1955-10-05 1963-01-17 Roland Vercambre Verfahren zur Gewinnung von Nucleinsaeure und deren Salze aus Fischmilch
GB808296A (en) * 1955-10-05 1959-02-04 Roland Vercambre Process for the extraction of nucleic acid and for the preparation of the salts thereof
FR1245818A (fr) * 1959-11-27 1960-10-03 Procédé de préparation d'acides désoxyribonucléiques à haut degré de polymérisation
FR1408585A (fr) * 1964-09-22 1965-08-13 Schwarz Biores Isolement et purification de bases hétérocycliques
IT1043823B (it) * 1970-11-03 1980-02-29 Prephar Procedimento per l estrazione di acidi nucleici da organi animali
US3899481A (en) * 1970-11-03 1975-08-12 Crinos Industria Farmaco Process for the controlled partial degradation of deoxyribonucleic acid extracted from animal organs
JPS5217040B2 (fr) * 1972-12-07 1977-05-12
SU780444A1 (ru) * 1979-06-25 1985-04-23 Специальное Конструкторско-Технологическое Бюро Биологически Активных Веществ Главного Управления Микробиологической Промышленности При Совете Министров Ссср Способ получени дезоксирибонуклеиновой кислоты
US4417046A (en) * 1981-08-24 1983-11-22 Eli Lilly And Company Process for isolating oligonucleotide product from a coupling reaction mixture
DE3308932A1 (de) * 1983-03-12 1984-09-13 Hoechst Ag, 6230 Frankfurt Verfahren zur abtrennung von ribonukleinsaeuren aus einer loesung, die desoxyribonukleinsaeuren enthaelt
SU1161511A1 (ru) * 1983-07-01 1985-06-15 Институт биоорганической химии АН БССР Способ осаждени нуклеиновых кислот из растворов,содержащих фосфатный буфер
JPS6036493A (ja) * 1983-08-08 1985-02-25 Nippon Zeon Co Ltd 保護された核酸関連物質の分離法
IT1206341B (it) * 1984-02-16 1989-04-14 Crinos Industria Farmaco Composizione farmaceutica per il trattamento dell'ischemia acuta del miocardio.
US4605644A (en) * 1985-02-07 1986-08-12 Regents Of The University Of Minnesota Method for stimulating recovery from ischemia employing ribose and adenine
IT1190313B (it) * 1986-04-17 1988-02-16 Crinos Industria Farmaco Procedimento per l'ottenimento di polidesossiribonucleotidi chimicamente definiti e riproducibili e prodotto farmacologicamente attivo risultante
JP2930589B2 (ja) * 1986-10-06 1999-08-03 ザ ユニバーシィティ オブ バージニア アルミニ パテンツ ファンデーション 外科手術中における改善された心臓保護のためのアデノシン，ヒポキサンチン及びリボース含有溶液の使用
US4833239A (en) * 1987-01-29 1989-05-23 Genetics Institute, Inc. Method for the isolation and purification of DNA molecules
US5063162A (en) * 1987-04-24 1991-11-05 Hoffmann-La Roche Inc. Process for isolating nucleic acids utilizing protease digestion
DE68914689T2 (de) * 1989-05-22 1994-10-27 Genetics Inst Verbesserte zusammensetzung zur isolierung und anreicherung von nukleinsäure und dadurch verbessertes verfahren.
IT1232318B (it) * 1989-09-07 1992-01-28 Crinos Industria Farmaco Composizioni ad uso topico contenenti acidi nucleici depolimerizzati per la cosmesi della pelle e del corpo.
US4997932A (en) * 1989-11-13 1991-03-05 Boehringer Mannheim Corporation Method and kit for purifying nucleic acids

Also Published As

Publication number Publication date
CA2083416A1 (fr) 1993-06-10
GR920100527A (el) 1994-03-31
MX9207137A (es) 1993-08-01
FR2684675A1 (fr) 1993-06-11
FR2684675B1 (fr) 1996-10-18
LU88197A1 (fr) 1993-05-17
AU655087B2 (en) 1994-12-01
ZA928878B (en) 1993-06-22
IT1252174B (it) 1995-06-05
EP0558833A2 (fr) 1993-09-08
AU2968592A (en) 1993-06-10
CH685298A5 (fr) 1995-05-31
ITMI913294A1 (it) 1993-06-09
JPH05247083A (ja) 1993-09-24
US6046172A (en) 2000-04-04
US5646127A (en) 1997-07-08
IL103757A (en) 1997-02-18
EP0558833A3 (en) 1995-09-06
ITMI913294A0 (it) 1991-12-09
BE1008163A5 (fr) 1996-02-06
PT101113A (pt) 1994-02-28
US5646268A (en) 1997-07-08
CN1073448A (zh) 1993-06-23
BR9204931A (pt) 1993-06-15

Similar Documents

Publication Publication Date Title
GR1002143B (en) New oligodeoxyribonucleotides having anti-ischemic activity and methods of preparation thereof.
GR3017062T3 (en) Piperidine compounds and their preparation and use.
GR3017837T3 (en) Hard foam and its preparation process.
ZA882452B (en) Use of n,n-dialkylhydroxylamines and their preparation
CS20091A2 (en) Basic calciumaluminiumhydroxidedicarboxylate, method of its preparation and its application
ZA899725B (en) N-aryl-azetidinones,their preparation process and their use as elastage inhibitors
EP0572025A3 (fr) Construction de meubles et méthode de fabrication.
IL93055A0 (en) Polyimidesiloxanes,their preparation and use
EP0344110A3 (en) Substituted naphthacenes-5,12-diones and their use
ZA889387B (en) New quaternary ammonium compounds,their preparation and use
JPS6479170A (en) Halogenated 1,3-dioxolane and derivatives
IL95637A0 (en) Pyridinyl-quinolone compounds,their preparation and use
EP0431700A3 (en) Propargyl compounds, and preparation thereof
DE3760415D1 (en) Benzaldehyde derivatives, their preparation and application
IL92281A0 (en) Polyimidesiloxanes,their preparation and use
JPS6468346A (en) Substituted anilinophenylthiourea, anilinophenylisothiourea and anilinophenylcarbodiimide
IL103142A0 (en) Substituted aminopropanes,processes for their preparation,and their use
EP0344109A3 (en) Substituted naphthacene-5,12-diones and their use
GB8918806D0 (en) Chiral compounds,their preparation and use
GR3017784T3 (en) Substituted dibenzofurans and methods of using same.
IL87779A0 (en) 4-azasaccharines,4-aza-dihydro-and-tetrahydro-saccharines and their preparation
ZA889251B (en) 8,9-annelated-beta-carbolines and 8,9-annelated-3,4-dihydro-beta-carbolines
IL85451A (en) 26, 27-mono- and 14,15:26,27-diepoxy g22-ll-f28249 derivatives and their pesticidal use
GB9124492D0 (en) Hoof hardeners,waterproofers and methods
ZA882852B (en) Pyrrolealdehydes,their preparation and their use